These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36394925)

  • 1. [Adequate and clinically effective levels of curcumin consumption].
    Kodentsova VM; Risnik DV; Sarkisyan VA; Frolova YV
    Vopr Pitan; 2022; 91(5):6-15. PubMed ID: 36394925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of newly developed food for special dietary use in the diet of patients with non-alcoholic steatohepatitis].
    Sasunova AN; Morozov SV; Sobolev RV; Isakov VA; Kochetkova AA; Vorobyeva IS
    Vopr Pitan; 2022; 91(2):31-42. PubMed ID: 35596633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is curcumin bioavailability a problem in humans: lessons from clinical trials.
    Kunnumakkara AB; Harsha C; Banik K; Vikkurthi R; Sailo BL; Bordoloi D; Gupta SC; Aggarwal BB
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):705-733. PubMed ID: 31361978
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions.
    Zou L; Liu W; Liu C; Xiao H; McClements DJ
    J Agric Food Chem; 2015 Feb; 63(7):2052-62. PubMed ID: 25639191
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Siudem P; Szeleszczuk Ł; Zielińska A; Paradowska K
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis.
    Khosravi MA; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3477-3491. PubMed ID: 37966571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of curcumin: problems and promises.
    Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
    Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of curcumin in digestive diseases.
    Dulbecco P; Savarino V
    World J Gastroenterol; 2013 Dec; 19(48):9256-70. PubMed ID: 24409053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food matrix and co-presence of turmeric compounds influence bioavailability of curcumin in healthy humans.
    Ahmed Nasef N; Loveday SM; Golding M; Martins RN; Shah TM; Clarke M; Coad J; Moughan PJ; Garg ML; Singh H
    Food Funct; 2019 Aug; 10(8):4584-4592. PubMed ID: 31347643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review.
    Slika L; Patra D
    Mini Rev Med Chem; 2020; 20(12):1072-1082. PubMed ID: 32286941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Curcumin: Correlation between Bioavailability and Health Potential.
    Dei Cas M; Ghidoni R
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31500361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assessment of Curcuma dietary supplements: Complementary data from LC-MS and
    Sorng S; Balayssac S; Danoun S; Assemat G; Mirre A; Cristofoli V; Le Lamer AC; Jullian V; Gilard V; Fabre N; Martino R; Malet-Martino M
    J Pharm Biomed Anal; 2022 Apr; 212():114631. PubMed ID: 35231794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
    Kharat M; McClements DJ
    J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary supplementation with curcumin nanomicelles, curcumin, and turmeric affects growth performance and silver nanoparticle toxicity in Cyprinus carpio.
    Pirani F; Moradi S; Ashouri S; Johari SA; Ghaderi E; Kim HP; Yu IJ
    Environ Sci Pollut Res Int; 2021 Dec; 28(45):64706-64718. PubMed ID: 34318423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology-applied curcumin for different diseases therapy.
    Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
    Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
    Mohanty C; Das M; Sahoo SK
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability.
    Abd El-Hack ME; El-Saadony MT; Swelum AA; Arif M; Abo Ghanima MM; Shukry M; Noreldin A; Taha AE; El-Tarabily KA
    J Sci Food Agric; 2021 Nov; 101(14):5747-5762. PubMed ID: 34143894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects.
    Kotha RR; Luthria DL
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31412624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.